Scancell Holdings plc (SCLP)

 

SCLP Share PerformanceMore

52 week high45.240 01/06/15
52 week low12.000 02/12/15
52 week change -14.000 (-44.44%)
4 week volume3,002,806 19/01/16

Media for (SCLP)

Presenter: Dr Richard Goodfellow
30/07/2015
Presenter: Dr Richard Goodfellow
01/06/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Scancell narrows H1 pretax loss

Scancell has narrowed its H1 pretax loss to GBP1.4m, from GBP1.5m. Its cash balance at Oct. 31, 2015, was GBP1.8m, versus GB...

Amendment to Options

RNS Number: 0851N Scancell Holdings Plc 27 January 2016 27 January 2016 Scancell Holdings Plc ("Scancell" or the "Company") Amendment to Options Scancell Holdings plc ('Scancell' LSE:AIM SCLP), the developer of novel immunotherapies for the treatment of cancer, announces an amendment to the time period for options granted to the joint Chief Executives, ...

Half Yearly Report

RNS Number: 0850N Scancell Holdings Plc 27 January 2016 27 January 2016 Scancell Holdings Plc Interim Results for the six months ended 31 October 2015 Scancell focuses on the US in a transformational year Scancell Holdings plc, ('Scancell' or the 'Company') the developer of novel immunotherapies for the treatment of cancer, announces its interim results for the ...

Scancell Holdings updates on SCIB1

Scancell Holdings has issued data showing patient immunologic response to cancer vaccine SCIB1 can be demonstrated thro...

SCIB1 Early Immune Effect Observed by ImmunTraCkeR

RNS Number: 3689L Scancell Holdings Plc 11 January 2016 Early Immune Effect of SCIB1 Cancer Vaccine Observed in Blood by ImmunTraCkeR Companion Diagnostic ImmunTraCkeR to be incorporated into SCIB1's upcoming Phase II checkpoint inhibitor combination clinical trial ImmunTraCkeR represents potential companion diagnostic for early detection of p...

Directorate Change

RNS Number: 0794L Scancell Holdings Plc 07 January 2016 Scancell Holdings Plc ("Scancell" or the "Company") Directorate Change Scancell Holdings Plc, (AIM:SCLP), today announcesthe appointment of John Chiplin as Non-Executive Chairman, succeeding current Chairman David Evans who has offered his resignation to the Board in line with his personal decisi...

SCLP notes paper on Moditope published

Scancell Holdings notes the online publication of a paper in Cancer Research describing the rationale behind the company...

Key Moditope paper published in Cancer Research

RNS Number: 7930K Scancell Holdings Plc 05 January 2016 05 January 2016 Scancell Holdings Plc ("Scancell" or the "Company") Key Moditope paper published in Cancer Research Moditope citrullinated peptides stimulate potent anti-tumour responses Scancell Holdings Plc, (AIM:SCLP), today announced the publication, on line, of a full paper in Cancer Research des...

Fundamental DataMore

EPS-1.03
Dividend yield0 %

Latest discussion posts More

  • What folks REALLY think of C7

    At the last SCLP AGM I attended, I overheard a couple of fellow shareholders 'chatting' about their thoughts on the 'character / reliabilty' of Elsie 7. Although they didn't ...
    12-Feb-2016
    kipngail
  • The GLUMs v Tosh123

    The CONstant attacks and increasingly childish abuse { a tactic set by the 'much lamented, enforced banishment, of the instigator of the trHYPE scam } ... towards Tosh123 , ...
    11-Feb-2016
    kipngail
  • A 'Clearer picture'

    Perhaps if one asks oneself tOO take a slightly different approach tOO the task in hand - One might 'alter' the scenario, from = If the trHYPER GLUM CLUB are sOO keen tOO ...
    10-Feb-2016
    kipngail

Users' HoldingsMore

Users who hold Scancell Holdings plc also hold..
LLOYDS GRP.20%
SIRIUS MINERALS15%
BARCLAYS11%
PREMAITHA10%
TESCO10%

Codes & Symbols

ISINGB00B63D3314
SymbolsSCLP, LSE:SCLP, SCLP.L, SCLP:LN, LON:SCLP, XLON:SCLP